NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth
NEW YORK, June 20, 2025 /PRNewswire/ -- The New York Stock Exchange…
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals…
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition…
FDA approves Novartis radioligand therapy Pluvicto for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer
Ad hoc announcement pursuant to Art. 53 LR New indication approximately triples…
Primo Partners with ABX to Bring PB01 Closer to Taiwans Prostate Cancer Market
TAIPEI, Taiwan, March 19, 2025 (GLOBE NEWSWIRE) -- In response to the…
Ibex Medical Analytics Receives First FDA 510(k) Clearance
FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer…
ProstaVive: Introducing ProstaVive as the New Standard of Prostate Support in 2025
TALLMADGE, Ohio, Jan. 17, 2025 (GLOBE NEWSWIRE) -- ProstaVive stands at the…
Illuccix Receives European Approval
January 16, 2025 17:06 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia…
HoLEP Awareness at Manipal Hospital Sarjapur Road: Advanced Solution for Elderly with Enlarged Prostate
BANGALORE, India, Jan. 15, 2025 /PRNewswire/ -- Manipal Hospitals Sarjapur Road recently…
Zenflow Announces $24 Million Financing Round to Fund FDA Filing & Commercial Preparation
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Zenflow, Inc.,…